Incorporating exposure-response modeling into the assessment of QTc interval: A potential alternative to the thorough QT study.
- 3 April 2015
- journal article
- editorial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 97 (5) , 444-6
Abstract
ICH E14 mandates that a thorough QTc study (TQT) is conducted as part of the clinical drug development program to provide an accurate and precise estimate of a drug's effect on the QTc. In the April issue of CPT, Darpo et al. report the results of a study which validated an alternative approach to evaluating the effect of a drug on QTc using exposure‐response modeling in phase I which has the potential to make the TQT study obsolete.Keywords
This publication has 3 references indexed in Scilit:
- The Cost-Effectiveness of Drug Regulation: The Example of Thorough QT/QTc StudiesClinical Pharmacology & Therapeutics, 2011
- Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure–Response Analysis: Case Study of a Thorough QT Study of AsenapineClinical Pharmacology & Therapeutics, 2010
- A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy SubjectsThe Journal of Clinical Pharmacology, 2009